0O1O.L

Vetoquinol SA [0O1O.L] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

0O1O.L Stock Summary

Top 10 Correlated Stocks

0O1O.L

In the News

0O1O.L Financial details

Company Rating
-
Market Cap
1.14B
Income
103.59M
Revenue
1.07B
Book val./share
-
Cash/share
-
Dividend
0.8
Dividend %
0.79%
Employees
2.5K
Optionable
No
Shortable
Yes
Earnings
-
P/E
20.5
Forward P/E
-
PEG
1.77
P/S
2.29
P/B
2.38
P/C
-
P/FCF
13.56
Quick Ratio
1.62
Current Ratio
2.68
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
8.75
EPS next Y
-
EPS next Q
-
EPS this Y
15.27%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
14.1%
Revenue last 5Y
5.98%
Revenue Q/Q
6.56%
EPS Q/Q
-27.57%
-
-
-
-
SMA20
-3.96%
SMA50
6.18%
SMA100
-6.29%
Inst Own
-
Inst Trans
-
ROA
9%
ROE
12%
ROC
0.17%
Gross Margin
56%
Oper. Margin
17%
Profit Margin
11%
Payout
16%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
76.6-108.99401
52W High
-31.57%
52W Low
-2.76%
RSI
42.26
Rel Volume
0.11
Avg Volume
141
Volume
16
Perf Week
-4.89%
Perf Month
2.21%
Perf Quarter
-
Perf Half Y
-10.86%
-
-
-
-
Beta
0.906
-
-
Volatility
1.55%, 3.5%
Prev Close
0.54%
Price
73.9
Change
-0.14%

0O1O.L Financial Performance

0O1O.L Dividend History

0O1O.L Frequently Asked Questions

What is Vetoquinol SA stock symbol ?

Vetoquinol SA is a FR stock and trading under the symbol 0O1O.L

What is Vetoquinol SA stock quote today ?

Vetoquinol SA stock price is $73.9 today.

Is Vetoquinol SA stock public?

Yes, Vetoquinol SA is a publicly traded company.

Something similar

Top by Market Cap
3V64.DE
MSFT
TL0.DE
1YD.DE
MIX.JO
Same Sector
ORCHPHARMA.NS
PROC
OGI
EVH
BWAY
Top Correlated Stocks
WINV
Similar Market Cap
BRIT3.SA
B4B3.DE
IMVU.L
CBE.PA
2215.HK

Company Profile

Healthcare Medical - Pharmaceuticals
  • Volume Average 141
  • Market Capitalization 1.14B
  • Employee 2.5K
  • CEO Mr. Matthieu Frechin
  • Headquarters Lure,FR
  • IPO Date 2013-03-05
  • Website https://www.vetoquinol.com

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, and dogs. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.